10x Genomics, Inc. (LON:0A88)
London · Delayed Price · Currency is GBP · Price in USD 12.58
+0.04 (0.28%)
At close: Aug 7, 2025
Activision Blizzard Market Cap
10x Genomics has a market cap or net worth of 1.17 billion as of August 8, 2025. Its market cap has decreased by -33.20% in one year.
Market Cap
1.17B
Enterprise Value
906.17M
Revenue
470.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
$12.58
Market Cap Chart
Since September 12, 2019, 10x Genomics's market cap has decreased from 4.01B to 1.17B, a decrease of -70.73%. That is a compound annual growth rate of -18.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 1.17B | -15.38% |
| Dec 31, 2024 | 1.39B | -73.26% |
| Dec 29, 2023 | 5.19B | 50.02% |
| Dec 30, 2022 | 3.46B | -71.83% |
| Dec 31, 2021 | 12.29B | 10.11% |
| Dec 31, 2020 | 11.16B | 101.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 173.99B |
| HSBC Holdings | 160.33B |
| Shell | 158.09B |
| Unilever | 112.29B |
| British American Tobacco p.l.c. | 91.73B |
| Rolls-Royce Holdings | 90.25B |
| Rio Tinto Group | 76.46B |
| RELX PLC | 66.69B |